+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Epigenetic Regulation of Cancer - Part D. International Review of Cell and Molecular Biology Volume 390

  • Book

  • March 2025
  • Region: Global
  • Elsevier Science and Technology
  • ID: 6016389
Epigenetic Regulation of Cancer, Part D, Volume 390 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of hot topics, including Revisiting Epigenetic Regulation in Cancer: Evolving Trends and Translational Implications, Epigenetic Alteration in Cervical Cancer Induced by Human Papillomavirus, Integrative analysis of transcriptome, chromatin accessibility, cell surface antigen in single cell level for AML, Role of miRNAs as epigenetic regulators of immune checkpoints in lung cancer immunity, and much more.

Other chapters cover The translational potential of epigenetic modulatory bioactive phytochemicals as adjuvant therapy against cancer, Strategies for improving chemotherapeutic sensitivity and the epigenetic regulation of doxorubicin resistance, and more.

Table of Contents

1. Preface
Sheila Spada
2. Revisiting Epigenetic Regulation in Cancer: Evolving Trends and Translational Implications
Hifzur R. Siddique, Ranjan Kumar, Dhruv Mishra and Mohammad Afsar Khan
3. Epigenetic Alteration in Cervical Cancer Induced by Human Papillomavirus
Maria Elizbeth Alvarez S�nchez, Elisa Elvira Figueroa Angulo, Jonathan Puente Rivera, Yussel Fernando Perez Navarro and Edgar Mendieta Condado
4. Integrative analysis of transcriptome, chromatin accessibility, cell surface antigen in single cell level for AML
Christopher E. Mason
5. Role of miRNAs as epigenetic regulators of immune checkpoints in lung cancer immunity
Jose Luis Garcia-Gimenez, Salvador Mena-Moll�, Irene Canovas-Cervera and Guillermo Suay-Montagud
6. The translational potential of epigenetic modulatory bioactive phytochemicals as adjuvant therapy against cancer
Syed Musthapa Meeran, Priya Mondal and Gowthami Jayaprakash
7. Strategies for improving chemotherapeutic sensitivity and the epigenetic regulation of doxorubicin resistance
Nageswaran Sivalingam and Sruthi Sritharan